Suchergebnisse - "Rosenblatt, Jacalyn"

PubPharm (144)

1

Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk) : a single-arm, phase 2 trial

enthalten in: The Lancet. Haematology | 2024

von O'Donnell, E. | Mo, C. | Yee, A. | +10

2

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

enthalten in: Europäisches Patentamt | 2024

von KUFE DONALD | AVIGAN DAVID | ROSENBLATT JACALYN | +1

3

PERSONALIZED FUSION CELL VACCINES

enthalten in: Europäisches Patentamt | 2024

von AVIGAN DAVID | ROSENBLATT JACALYN | KUFE DONALD

4

Immune checkpoint blockade in hematological malignancies : current state and future potential

enthalten in: Frontiers in oncology | 2024

von Pophali, P. | Varela, J. | Rosenblatt, J.

5

Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma : BMT CTN 1401

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Chung, D. | Shah, N. | Wu, J. | +36

CommentIn: Clin Cancer Res. 2023 Dec 1;29(23):4703-4705. - PMID 37733765

6

Idecabtagene vicleucel for relapsed and refractory multiple myeloma : post hoc 18-month follow-up of a phase 1 trial

enthalten in: Nature medicine | 2023

von Lin, Y. | Raje, N. | Berdeja, J. | +19

7

Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease

enthalten in: Blood | 2023

von Koshy, A. | Kim, H. | Liegel, J. | +20

CommentIn: Blood. 2023 Jun 15;141(24):2913-2914. - PMID 37318907

8

Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma

enthalten in: Blood advances | 2023

von Frigault, M. | Bishop, M. | Rosenblatt, J. | +15

9

Personalized tumor vaccine for pancreatic cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Orr, S. | Huang, L. | Moser, J. | +13

10

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma

enthalten in: Cancer cell | 2022

von Sklavenitis-Pistofidis, R. | Aranha, M. | Redd, R. | +36

CommentIn: Cancer Cell. 2022 Nov 14;40(11):1270-1272. - PMID 36379204

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]